Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Microglia Pathogen Phagocytosis Pathway WP3937,3.5711199593754517e-06,17.649811726734804,221.37508095448942,"['NCF2', 'ARPC1B', 'NCF4', 'ITGB2', 'CYBB', 'CYBA']",0.0007713619112250976,0,0,6
2,TYROBP causal network in microglia WP3945,8.013184139197906e-06,11.209653755868544,131.53881162887978,"['CD4', 'SLC7A7', 'NCF2', 'ITGB2', 'IL18', 'CYTL1', 'SLC1A5']",0.0008654238870333739,0,0,7
3,Macrophage markers WP4146,0.000125948320205339,45.032876712328765,404.37897115595865,"['CD163', 'CD14', 'CD68']",0.009068279054784408,0,0,3
4,Cytokines and Inflammatory Response WP530,0.00026461377825581875,32.160469667318985,264.9134825796603,"['CD4', 'HLA-DRA', 'HLA-DRB1']",0.014289144025814212,0,0,3
5,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.0003602733979405927,28.137842465753426,223.0950308329015,"['CD4', 'HLA-DRA', 'HLA-DRB1']",0.015563810791033604,0,0,3
6,Vitamin D Receptor Pathway WP2877,0.0007182513418636085,5.147142470205851,37.25857383293156,"['LRRC25', 'COLEC11', 'CRACR2A', 'ALOX5', 'TNFRSF11B', 'CD14', 'HLA-DRB1']",0.02381066171593808,0,0,7
7,Eicosanoid Synthesis WP167,0.0007716418148683636,20.458281444582813,146.62430028961234,"['ALOX5', 'ALOX5AP', 'PTGS1']",0.02381066171593808,0,0,3
8,Type II interferon signaling (IFNG) WP619,0.0016631391207306359,14.997260273972604,95.96819474729297,"['HLA-B', 'CYBB', 'PSMB9']",0.04490475625972717,0,0,3
9,Allograft Rejection WP2328,0.0021385646224332234,8.146132339235788,50.079329448956116,"['HLA-B', 'HLA-DRA', 'HLA-DOA', 'HLA-DRB1']",0.05132555093839736,0,0,4
10,Cytosine methylation WP3585,0.002585943764960808,37.275510204081634,222.07499298817504,"['TDG', 'IDH2']",0.05585638532315346,0,0,2
11,Ebola Virus Pathway on Host WP4217,0.003293095277510494,5.403273809523809,30.884720507734876,"['HLA-B', 'HLA-DRA', 'MAPK1', 'HLA-DOA', 'HLA-DRB1']",0.06466441635838788,0,0,5
12,LTF danger signal response pathway WP4478,0.009073518920980423,16.55933484504913,77.86853530702219,"['MAPK1', 'CD14']",0.1633233405776476,0,0,2
13,Kallmann's Syndrome WP5074,0.01894876503777179,10.640427599611273,42.20011163021872,"['MAPK1', 'GNRH1']",0.31484101908913126,0,0,2
14,IL1 and megakaryocytes in obesity WP2865,0.021288656156791996,9.93015873015873,38.22694960932145,"['TLR1', 'IL18']",0.32845355213336225,0,0,2
15,Acute viral myocarditis WP4298,0.030803756449059895,4.672517123287672,16.26091390753865,"['CD4', 'ITGB2', 'MAPK1']",0.3908840518527706,0,0,3
16,T-cell receptor (TCR) signaling pathway WP69,0.03237726068929626,4.576740285155158,15.699587317515855,"['CD4', 'MAPK1', 'CRKL']",0.3908840518527706,0,0,3
17,Selenium Micronutrient Network WP15,0.03734511980849271,4.3115121180189675,14.174324757762253,"['ALOX5', 'ALOX5AP', 'PTGS1']",0.3908840518527706,0,0,3
18,Regulation of Actin Cytoskeleton WP51,0.037447584098199746,3.33272030651341,10.947363258686792,"['CHRM5', 'MAPK1', 'CD14', 'FGF1']",0.3908840518527706,0,0,4
19,Metabolism of alpha-linolenic acid WP4586,0.03969310841445235,37.0304054054054,119.48148022650835,['ALOX5'],0.3908840518527706,0,0,1
20,Signaling of Hepatocyte Growth Factor Receptor WP313,0.040653954907509934,6.766233766233766,21.66994052322182,"['MAPK1', 'CRKL']",0.3908840518527706,0,0,2
21,Nuclear Receptors Meta-Pathway WP2882,0.04266541651186855,2.457965947096382,7.753325698919636,"['SERPINA1', 'SLC6A9', 'SLCO2B1', 'ALOX5AP', 'DBI', 'SLC5A3']",0.3908840518527706,0,0,6
22,Common Pathways Underlying Drug Addiction WP2636,0.04380847105366005,6.471458148476782,20.242255643356508,"['MAPK1', 'DRD1']",0.3908840518527706,0,0,2
23,Toll-like Receptor Signaling Pathway WP75,0.044538689083875316,4.002079256360078,12.452057591782149,"['TLR1', 'MAPK1', 'CD14']",0.3908840518527706,0,0,3
24,Sleep regulation WP3591,0.04705085809338905,6.20124716553288,18.954274280416254,"['IL18', 'DRD1']",0.3908840518527706,0,0,2
25,Toll-like Receptor Signaling related to MyD88 WP3858,0.04705085809338905,6.20124716553288,18.954274280416254,"['TLR1', 'MAPK1']",0.3908840518527706,0,0,2
26,Monoamine GPCRs WP58,0.04705085809338905,6.20124716553288,18.954274280416254,"['CHRM5', 'DRD1']",0.3908840518527706,0,0,2
27,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.050378227326746045,5.95265306122449,17.787695226085855,"['ITGB2', 'CD14']",0.40302581861396836,0,0,2
28,IL-2 signaling pathway WP49,0.05378775080615061,5.723181580324438,16.727197277601753,"['MAPK1', 'CRKL']",0.41493407764744755,0,0,2
29,Complement system WP2806,0.05864769664867085,3.5551206784083496,10.083058073889767,"['FCGR3A', 'ITGB2', 'VSIG4']",0.43682422331423804,0,0,3
30,Metabolic reprogramming in colon cancer WP4290,0.06084224587326696,5.313411078717201,14.874739683199152,"['IDH2', 'SLC1A5']",0.43806417028752215,0,0,2
31,TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868,0.06528176226342486,18.511824324324323,50.51955668930574,['MAPK1'],0.44065189527811777,0,0,1
32,"Cerebral organic acidurias, including diseases WP4519",0.06528176226342486,18.511824324324323,50.51955668930574,['IDH2'],0.44065189527811777,0,0,1
33,Proteasome Degradation WP183,0.06819289357844355,4.95827664399093,13.315030073747616,"['HLA-B', 'PSMB9']",0.4414297316257015,0,0,2
34,Aspirin and miRNAs WP4707,0.0778209488022217,14.808108108108108,37.81020315885849,['PTGS1'],0.4414297316257015,0,0,1
35,Hematopoietic Stem Cell Differentiation WP2849,0.0797294466388382,4.5062873634302205,11.396924791477387,"['RHOH', 'ACVR1B']",0.4414297316257015,0,0,2
36,Lung fibrosis WP3624,0.0797294466388382,4.5062873634302205,11.396924791477387,"['SERPINA1', 'FGF1']",0.4414297316257015,0,0,2
37,IL-3 signaling pathway WP286,0.08370133536086324,4.373349339735895,10.84809455687417,"['MAPK1', 'CRKL']",0.4414297316257015,0,0,2
38,Pathogenic Escherichia coli infection WP2272,0.08370133536086324,4.373349339735895,10.84809455687417,"['ARPC1B', 'CD14']",0.4414297316257015,0,0,2
39,Bile acids synthesis and enterohepatic circulation  WP4389,0.09019303874463556,12.338963963963964,29.685116899855327,['MAPK1'],0.4414297316257015,0,0,1
40,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.09019303874463556,12.338963963963964,29.685116899855327,['MAPK1'],0.4414297316257015,0,0,1
41,RANKL/RANK signaling pathway WP2018,0.09182062113745176,4.12962962962963,9.861218476414205,"['MAPK1', 'TNFRSF11B']",0.4414297316257015,0,0,2
42,MET in type 1 papillary renal cell carcinoma WP4205,0.09596351260263525,4.017650303364589,9.416517503022986,"['MAPK1', 'CRKL']",0.4414297316257015,0,0,2
43,"GPCRs, Class A Rhodopsin-like WP455",0.09935597101918281,2.353733369535705,5.434879118496423,"['GPR65', 'PTAFR', 'CHRM5', 'DRD1']",0.4414297316257015,0,0,4
44,Regulation of toll-like receptor signaling pathway WP1449,0.10028996700217359,2.795291095890411,6.428301915040025,"['TLR1', 'MAPK1', 'CD14']",0.4414297316257015,0,0,3
45,Cancer immunotherapy by CTLA4 blockade WP4582,0.10240024341762698,10.575289575289576,24.099669854700792,['HLA-DRB1'],0.4414297316257015,0,0,1
46,Osteoclast Signaling WP12,0.10240024341762698,10.575289575289576,24.099669854700792,['TNFRSF11B'],0.4414297316257015,0,0,1
47,NRF2 pathway WP2884,0.10860866172167498,2.693513781152005,5.979611682374141,"['SERPINA1', 'SLC6A9', 'SLC5A3']",0.4414297316257015,0,0,3
48,Kit receptor signaling pathway WP304,0.10869917230218328,3.7153061224489794,8.244899972360042,"['MAPK1', 'CRKL']",0.4414297316257015,0,0,2
49,PPAR signaling pathway WP3942,0.11303977217712553,3.6243570598971298,7.901154771168784,"['DBI', 'CPT1B']",0.4414297316257015,0,0,2
50,Small Ligand GPCRs WP247,0.11444474523629297,9.252533783783784,20.05637649781365,['PTAFR'],0.4414297316257015,0,0,1
51,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.11444474523629297,9.252533783783784,20.05637649781365,['IDH2'],0.4414297316257015,0,0,1
52,Farnesoid X receptor pathway WP2879,0.11444474523629297,9.252533783783784,20.05637649781365,['SLCO2B1'],0.4414297316257015,0,0,1
53,IL-9 signaling pathway WP22,0.11444474523629297,9.252533783783784,20.05637649781365,['MAPK1'],0.4414297316257015,0,0,1
54,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.11444474523629297,9.252533783783784,20.05637649781365,['MAPK1'],0.4414297316257015,0,0,1
55,Osteoblast Signaling WP322,0.11444474523629297,9.252533783783784,20.05637649781365,['TNFRSF11B'],0.4414297316257015,0,0,1
56,Osteopontin Signaling WP1434,0.11444474523629297,9.252533783783784,20.05637649781365,['MAPK1'],0.4414297316257015,0,0,1
57,"GPCRs, Class B Secretin-like WP334",0.12632869806897626,8.223723723723724,17.01379929683387,['ADGRE1'],0.443223520658858,0,0,1
58,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.12632869806897626,8.223723723723724,17.01379929683387,['MAPK1'],0.443223520658858,0,0,1
59,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.12632869806897626,8.223723723723724,17.01379929683387,['MAPK1'],0.443223520658858,0,0,1
60,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.12632869806897626,8.223723723723724,17.01379929683387,['MAPK1'],0.443223520658858,0,0,1
61,miR-509-3p alteration of YAP1/ECM axis WP3967,0.12632869806897626,8.223723723723724,17.01379929683387,['GPC6'],0.443223520658858,0,0,1
62,Endometrial cancer WP4155,0.13082621228655436,3.3009826152683295,6.7138205458712,"['MAPK1', 'FGF1']",0.443223520658858,0,0,2
63,Selective expression of chemokine receptors during T-cell polarization WP4494,0.13805422750601937,7.400675675675676,14.654142425003268,['CD4'],0.443223520658858,0,0,1
64,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.13805422750601937,7.400675675675676,14.654142425003268,['MAPK1'],0.443223520658858,0,0,1
65,Development and heterogeneity of the ILC family WP3893,0.13805422750601937,7.400675675675676,14.654142425003268,['IL18'],0.443223520658858,0,0,1
66,ERK Pathway in Huntington's Disease WP3853,0.13805422750601937,7.400675675675676,14.654142425003268,['MAPK1'],0.443223520658858,0,0,1
67,Fatty acid transporters WP5061,0.13805422750601937,7.400675675675676,14.654142425003268,['DBI'],0.443223520658858,0,0,1
68,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.14340068520569071,1.8591072415699281,3.6105955475636593,"['CSF3R', 'CAB39L', 'ITGB2', 'MAPK1', 'FGF1']",0.443223520658858,0,0,5
69,Regulatory circuits of the STAT3 signaling pathway WP4538,0.1445591317313188,3.0938208616780045,5.983655715619983,"['CSF3R', 'MAPK1']",0.443223520658858,0,0,2
70,IL-18 signaling pathway WP4754,0.14738351703770985,2.0158434296365333,3.8597699465060202,"['NCF2', 'IL18', 'MAPK1', 'TNFRSF11B']",0.443223520658858,0,0,4
71,Cells and molecules involved in local acute inflammatory response  WP4493,0.14962343123161878,6.7272727272727275,12.779353307923781,['ITGB2'],0.443223520658858,0,0,1
72,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.16103837938707952,6.166103603603603,11.25999924370642,['MAPK1'],0.443223520658858,0,0,1
73,Type II diabetes mellitus WP1584,0.16103837938707952,6.166103603603603,11.25999924370642,['MAPK1'],0.443223520658858,0,0,1
74,Hypertrophy Model WP516,0.16103837938707952,6.166103603603603,11.25999924370642,['IL18'],0.443223520658858,0,0,1
75,Overview of nanoparticle effects WP3287,0.16103837938707952,6.166103603603603,11.25999924370642,['PTGS1'],0.443223520658858,0,0,1
76,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.16103837938707952,6.166103603603603,11.25999924370642,['HLA-DRA'],0.443223520658858,0,0,1
77,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.17230111493679576,5.6912681912681915,10.008161500512735,['MAPK1'],0.443223520658858,0,0,1
78,Cancer immunotherapy by PD-1 blockade WP4585,0.17230111493679576,5.6912681912681915,10.008161500512735,['HLA-DRB1'],0.443223520658858,0,0,1
79,Physiological and pathological hypertrophy of the heart WP1528,0.17230111493679576,5.6912681912681915,10.008161500512735,['MAPK1'],0.443223520658858,0,0,1
80,PPAR-alpha pathway WP2878,0.17230111493679576,5.6912681912681915,10.008161500512735,['DBI'],0.443223520658858,0,0,1
81,Corticotropin-releasing hormone signaling pathway WP2355,0.17283456309222564,2.748551272360796,4.82486304188753,"['IL18', 'MAPK1']",0.443223520658858,0,0,2
82,MAPK Signaling Pathway WP382,0.1755441251748744,1.8744740837128606,3.2613315558304206,"['MAPK1', 'CD14', 'FGF1', 'CRKL']",0.443223520658858,0,0,4
83,Signal Transduction of S1P Receptor WP26,0.18341365392365236,5.284266409266409,8.96217539994738,['MAPK1'],0.443223520658858,0,0,1
84,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.18341365392365236,5.284266409266409,8.96217539994738,['MAPK1'],0.443223520658858,0,0,1
85,ErbB signaling pathway WP673,0.19214956133512778,2.558057705840957,4.219468209164837,"['MAPK1', 'CRKL']",0.443223520658858,0,0,2
86,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.19437798593375927,4.931531531531531,8.077605200879978,['TLR1'],0.443223520658858,0,0,1
87,Statin inhibition of cholesterol production WP430,0.19437798593375927,4.931531531531531,8.077605200879978,['APOC1'],0.443223520658858,0,0,1
88,Ebstein-Barr virus LMP1 signaling WP262,0.19437798593375927,4.931531531531531,8.077605200879978,['MAPK1'],0.443223520658858,0,0,1
89,Purinergic signaling WP4900,0.19437798593375927,4.931531531531531,8.077605200879978,['P2RX6'],0.443223520658858,0,0,1
90,22q11.2 copy number variation syndrome WP4657,0.2019122880650371,2.4723356009070296,3.955543855675107,"['P2RX6', 'CRKL']",0.443223520658858,0,0,2
91,TNF-alpha signaling pathway WP231,0.2019122880650371,2.4723356009070296,3.955543855675107,"['MAPK1', 'CYBA']",0.443223520658858,0,0,2
92,Cannabinoid receptor signaling WP3869,0.20519607437910092,4.622888513513513,7.321681346960609,['MAPK1'],0.443223520658858,0,0,1
93,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.20519607437910092,4.622888513513513,7.321681346960609,['PTGS1'],0.443223520658858,0,0,1
94,EPO Receptor Signaling WP581,0.20519607437910092,4.622888513513513,7.321681346960609,['MAPK1'],0.443223520658858,0,0,1
95,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.20519607437910092,4.622888513513513,7.321681346960609,['MAPK1'],0.443223520658858,0,0,1
96,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.20519607437910092,4.622888513513513,7.321681346960609,['MAPK1'],0.443223520658858,0,0,1
97,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.20519607437910092,4.622888513513513,7.321681346960609,['MAPK1'],0.443223520658858,0,0,1
98,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.20519607437910092,4.622888513513513,7.321681346960609,['MAPK1'],0.443223520658858,0,0,1
99,IL-7 signaling pathway WP205,0.20519607437910092,4.622888513513513,7.321681346960609,['MAPK1'],0.443223520658858,0,0,1
100,"Relationship between inflammation, COX-2 and EGFR WP4483",0.20519607437910092,4.622888513513513,7.321681346960609,['MAPK1'],0.443223520658858,0,0,1
101,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.21586985680152315,4.350556438791733,6.669749184396926,['ALOX5'],0.44475738596562964,0,0,1
102,Estrogen signaling pathway WP712,0.21586985680152315,4.350556438791733,6.669749184396926,['MAPK1'],0.44475738596562964,0,0,1
103,Nanoparticle-mediated activation of receptor signaling WP2643,0.21586985680152315,4.350556438791733,6.669749184396926,['MAPK1'],0.44475738596562964,0,0,1
104,RAS and bradykinin pathways in COVID-19 WP4969,0.21586985680152315,4.350556438791733,6.669749184396926,['MAPK1'],0.44475738596562964,0,0,1
105,Male infertility WP4673,0.21665866009909082,2.3539574559982723,3.6002182337265176,"['EPSTI1', 'HLA-DRA']",0.44475738596562964,0,0,2
106,Angiogenesis WP1539,0.22640124531191444,4.108483483483483,6.102932132185998,['MAPK1'],0.44475738596562964,0,0,1
107,Disruption of postsynaptic signaling by CNV WP4875,0.22640124531191444,4.108483483483483,6.102932132185998,['MAPK1'],0.44475738596562964,0,0,1
108,B Cell Receptor Signaling Pathway WP23,0.22654359052466144,2.2811093668236526,3.387032019553577,"['MAPK1', 'CRKL']",0.44475738596562964,0,0,2
109,Integrin-mediated Cell Adhesion WP185,0.2364610155082652,2.212610417301249,3.1905221003349395,"['ITGB2', 'MAPK1']",0.44475738596562964,0,0,2
110,Base Excision Repair WP4752,0.2367921267872565,3.891891891891892,5.606552918489456,['TDG'],0.44475738596562964,0,0,1
111,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.2367921267872565,3.891891891891892,5.606552918489456,['TNFRSF11B'],0.44475738596562964,0,0,1
112,Fatty acid beta-oxidation WP143,0.2367921267872565,3.891891891891892,5.606552918489456,['CPT1B'],0.44475738596562964,0,0,1
113,GABA receptor Signaling WP4159,0.2367921267872565,3.891891891891892,5.606552918489456,['GABRA4'],0.44475738596562964,0,0,1
114,Oxidative Stress WP408,0.2367921267872565,3.891891891891892,5.606552918489456,['CYBB'],0.44475738596562964,0,0,1
115,Resistin as a regulator of inflammation WP4481,0.2367921267872565,3.891891891891892,5.606552918489456,['MAPK1'],0.44475738596562964,0,0,1
116,Fluoropyrimidine Activity WP1601,0.24704436335827304,3.6969594594594595,5.169041948732375,['TDG'],0.4552993049550893,0,0,1
117,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.24704436335827304,3.6969594594594595,5.169041948732375,['GABRA4'],0.4552993049550893,0,0,1
118,ESC Pluripotency Pathways WP3931,0.25137921630935056,2.117201166180758,2.9234158258645997,"['MAPK1', 'FGF1']",0.4552993049550893,0,0,2
119,MAPK Cascade WP422,0.2571597926135227,3.5205920205920207,4.781166842156631,['MAPK1'],0.4552993049550893,0,0,1
120,miRNA regulation of prostate cancer signaling pathways WP3981,0.2571597926135227,3.5205920205920207,4.781166842156631,['MAPK1'],0.4552993049550893,0,0,1
121,Monoamine Transport WP727,0.2571597926135227,3.5205920205920207,4.781166842156631,['TNFRSF11B'],0.4552993049550893,0,0,1
122,Prion disease pathway WP3995,0.2571597926135227,3.5205920205920207,4.781166842156631,['MAPK1'],0.4552993049550893,0,0,1
123,BDNF-TrkB Signaling WP3676,0.2671402278730915,3.3602579852579852,4.4354785788065,['MAPK1'],0.4579546763538711,0,0,1
124,CAMKK2  Pathway WP4874,0.2671402278730915,3.3602579852579852,4.4354785788065,['MAPK1'],0.4579546763538711,0,0,1
125,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.2671402278730915,3.3602579852579852,4.4354785788065,['MAPK1'],0.4579546763538711,0,0,1
126,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.2671402278730915,3.3602579852579852,4.4354785788065,['MAPK1'],0.4579546763538711,0,0,1
127,Osteoblast differentiation WP4787,0.2762885039397108,1.9751473922902494,2.540651160919972,"['MAPK1', 'FGF1']",0.46022531602040195,0,0,2
128,Endothelin Pathways WP2197,0.2769874587159826,3.2138660399529964,4.12590674453401,['MAPK1'],0.46022531602040195,0,0,1
129,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.2769874587159826,3.2138660399529964,4.12590674453401,['FGF1'],0.46022531602040195,0,0,1
130,PDGF Pathway WP2526,0.2769874587159826,3.2138660399529964,4.12590674453401,['MAPK1'],0.46022531602040195,0,0,1
131,Bladder cancer WP2828,0.28670325110646816,3.0796734234234235,3.8474593099442247,['MAPK1'],0.4656233251052415,0,0,1
132,Heart Development WP1591,0.28670325110646816,3.0796734234234235,3.8474593099442247,['MAPK1'],0.4656233251052415,0,0,1
133,IL17 signaling pathway WP2112,0.28670325110646816,3.0796734234234235,3.8474593099442247,['MAPK1'],0.4656233251052415,0,0,1
134,Alpha 6 Beta 4 signaling pathway WP244,0.2962893476751686,2.956216216216216,3.5959969118998845,['MAPK1'],0.47406295628026984,0,0,1
135,G13 Signaling Pathway WP524,0.2962893476751686,2.956216216216216,3.5959969118998845,['ARHGDIB'],0.47406295628026984,0,0,1
136,IL-6 signaling pathway WP364,0.30574746825555743,2.8422557172557172,3.368061044524267,['MAPK1'],0.479766398817177,0,0,1
137,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.30574746825555743,2.8422557172557172,3.368061044524267,['MAPK1'],0.479766398817177,0,0,1
138,Spinal Cord Injury WP2431,0.3110696921677729,1.8053758088601295,2.1082064803111233,"['TNFSF13', 'MAPK1']",0.479766398817177,0,0,2
139,Fas ligand pathway and stress induction of heat shock proteins WP314,0.31507930988682753,2.7367367367367366,3.160741807175019,['ARHGDIB'],0.479766398817177,0,0,1
140,Interleukin-11 Signaling Pathway WP2332,0.31507930988682753,2.7367367367367366,3.160741807175019,['MAPK1'],0.479766398817177,0,0,1
141,Neovascularisation processes WP4331,0.31507930988682753,2.7367367367367366,3.160741807175019,['MAPK1'],0.479766398817177,0,0,1
142,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.3242865473486474,2.6387548262548264,2.971575031726418,['MAPK1'],0.479766398817177,0,0,1
143,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.3242865473486474,2.6387548262548264,2.971575031726418,['MAPK1'],0.479766398817177,0,0,1
144,Differentiation Pathway WP2848,0.3242865473486474,2.6387548262548264,2.971575031726418,['FGF1'],0.479766398817177,0,0,1
145,Ferroptosis WP4313,0.3242865473486474,2.6387548262548264,2.971575031726418,['CYBB'],0.479766398817177,0,0,1
146,IL-5 signaling pathway WP127,0.3242865473486474,2.6387548262548264,2.971575031726418,['MAPK1'],0.479766398817177,0,0,1
147,Aryl Hydrocarbon Receptor Netpath WP2586,0.33337083335375495,2.5475302889095994,2.7984614999566277,['MAPK1'],0.48327583895577897,0,0,1
148,Wnt Signaling Pathway WP363,0.33337083335375495,2.5475302889095994,2.7984614999566277,['MAPK1'],0.48327583895577897,0,0,1
149,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.33337083335375495,2.5475302889095994,2.7984614999566277,['MAPK1'],0.48327583895577897,0,0,1
150,Vitamin A and carotenoid metabolism WP716,0.3423337987775379,2.4623873873873876,2.6396029405912778,['MAPK1'],0.48647434563123804,0,0,1
151,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.3423337987775379,2.4623873873873876,2.6396029405912778,['ITGB2'],0.48647434563123804,0,0,1
152,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.3423337987775379,2.4623873873873876,2.6396029405912778,['IL18'],0.48647434563123804,0,0,1
153,Chemokine signaling pathway WP3929,0.3503825037302137,1.6436885865457294,1.723785290474603,"['MAPK1', 'CRKL']",0.49256002242573294,0,0,2
154,Prostaglandin Synthesis and Regulation WP98,0.351177053025754,2.3827375762859635,2.493450901433391,['PTGS1'],0.49256002242573294,0,0,1
155,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.35990218439202915,2.3080658783783785,2.3586655938756462,['CD4'],0.4983261014658865,0,0,1
156,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.35990218439202915,2.3080658783783785,2.3586655938756462,['MAPK1'],0.4983261014658865,0,0,1
157,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.36851076012143663,2.237919737919738,2.234082529106323,['MAPK1'],0.5031298457395061,0,0,1
158,Cytosolic DNA-sensing pathway WP4655,0.36851076012143663,2.237919737919738,2.234082529106323,['IL18'],0.5031298457395061,0,0,1
159,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.3770043268435944,2.171899841017488,2.1186852858784126,['DBI'],0.5031298457395061,0,0,1
160,p53 transcriptional gene network WP4963,0.3770043268435944,2.171899841017488,2.1186852858784126,['NCF2'],0.5031298457395061,0,0,1
161,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.37937427975282023,1.5401077097505669,1.4927216998859132,"['NCF2', 'MAPK1']",0.5031298457395061,0,0,2
162,Breast cancer pathway WP4262,0.3841557650787224,1.5240900483904902,1.4581078776571583,"['MAPK1', 'FGF1']",0.5031298457395061,0,0,2
163,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3853844108599203,2.1096525096525096,2.011583146271021,['MAPK1'],0.5031298457395061,0,0,1
164,Interferon type I signaling pathways WP585,0.3853844108599203,2.1096525096525096,2.011583146271021,['CRKL'],0.5031298457395061,0,0,1
165,Phosphodiesterases in neuronal function WP4222,0.3853844108599203,2.1096525096525096,2.011583146271021,['DRD1'],0.5031298457395061,0,0,1
166,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.3936525181943358,2.0508633633633635,1.9119926214575584,['MAPK1'],0.5031298457395061,0,0,1
167,Cardiac Hypertrophic Response WP2795,0.3936525181943358,2.0508633633633635,1.9119926214575584,['MAPK1'],0.5031298457395061,0,0,1
168,IL-4 signaling pathway WP395,0.3936525181943358,2.0508633633633635,1.9119926214575584,['MAPK1'],0.5031298457395061,0,0,1
169,Modulators of TCR signaling and T cell activation WP5072,0.3936525181943358,2.0508633633633635,1.9119926214575584,['RHOH'],0.5031298457395061,0,0,1
170,IL-1 signaling pathway WP195,0.40181013527421505,1.9952520087655223,1.8192221019226051,['MAPK1'],0.5075496445569032,0,0,1
171,Netrin-UNC5B signaling pathway WP4747,0.40181013527421505,1.9952520087655223,1.8192221019226051,['MAPK1'],0.5075496445569032,0,0,1
172,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.4256346148134329,1.8451013513513514,1.5760376246855625,['TNFRSF11B'],0.5258808144731444,0,0,1
173,Glucocorticoid Receptor Pathway WP2880,0.4256346148134329,1.8451013513513514,1.5760376246855625,['ALOX5AP'],0.5258808144731444,0,0,1
174,Prader-Willi and Angelman Syndrome WP3998,0.4256346148134329,1.8451013513513514,1.5760376246855625,['GNRH1'],0.5258808144731444,0,0,1
175,AMP-activated protein kinase (AMPK) signaling WP1403,0.4333647452602764,1.7999340804218853,1.505060847639486,['CPT1B'],0.5258808144731444,0,0,1
176,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.4333647452602764,1.7999340804218853,1.505060847639486,['MAPK1'],0.5258808144731444,0,0,1
177,Oncostatin M Signaling Pathway WP2374,0.4333647452602764,1.7999340804218853,1.505060847639486,['MAPK1'],0.5258808144731444,0,0,1
178,Proximal tubule transport WP4917,0.4333647452602764,1.7999340804218853,1.505060847639486,['SLC7A7'],0.5258808144731444,0,0,1
179,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.44099152793298707,1.7569176319176318,1.4384404959381853,['MAPK1'],0.5291898335195845,0,0,1
180,Complement and Coagulation Cascades WP558,0.44099152793298707,1.7569176319176318,1.4384404959381853,['SERPINA1'],0.5291898335195845,0,0,1
181,EGF/EGFR signaling pathway WP437,0.4447419299402829,1.3423623995052567,1.0876640314153927,"['MAPK1', 'CRKL']",0.5307417506469675,0,0,2
182,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.4485163353134561,1.715901948460088,1.3758276433672652,['MAPK1'],0.5323051012511347,0,0,1
183,Melanoma WP4685,0.47049236046961335,1.60355464159812,1.2090410042954263,['MAPK1'],0.5523171188121548,0,0,1
184,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.47049236046961335,1.60355464159812,1.2090410042954263,['MAPK1'],0.5523171188121548,0,0,1
185,AGE/RAGE pathway WP2324,0.48465752590407324,1.5364583333333333,1.112876390837671,['MAPK1'],0.5598183186913359,0,0,1
186,Alzheimer's disease WP2059,0.48465752590407324,1.5364583333333333,1.112876390837671,['MAPK1'],0.5598183186913359,0,0,1
187,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.48465752590407324,1.5364583333333333,1.112876390837671,['MAPK1'],0.5598183186913359,0,0,1
188,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.49844622522094406,1.4747297297297297,1.0267946853887349,['MAPK1'],0.5696528288239361,0,0,1
189,Non-small cell lung cancer WP4255,0.49844622522094406,1.4747297297297297,1.0267946853887349,['MAPK1'],0.5696528288239361,0,0,1
190,Leptin signaling pathway WP2034,0.5052025164683904,1.4456809750927397,0.9871050531779811,['MAPK1'],0.5743354924061702,0,0,1
191,Prolactin Signaling Pathway WP2037,0.5376516246296766,1.3159990347490347,0.8166359188362584,['MAPK1'],0.6080248739267547,0,0,1
192,Glioblastoma signaling pathways WP2261,0.5438831694240028,1.2927927927927927,0.7873377232392021,['MAPK1'],0.6118685656020032,0,0,1
193,VEGFA-VEGFR2 Signaling Pathway WP3888,0.550747230092252,1.026168448876607,0.6120882613107703,"['NCF2', 'IDH2', 'MAPK1', 'CYBB']",0.616380319688738,0,0,4
194,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.5560970693791514,1.2487402656894182,0.7327762907116054,['MAPK1'],0.6191596236386427,0,0,1
195,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5620816291368703,1.2278153153153153,0.7073544614915441,['MAPK1'],0.620852775790193,0,0,1
196,Focal Adhesion WP306,0.5669160069209168,1.059462633974453,0.6012917905704628,"['MAPK1', 'CRKL']",0.620852775790193,0,0,2
197,Thermogenesis WP4321,0.5679860408472656,1.2075764288879043,0.6830757947625836,['CPT1B'],0.620852775790193,0,0,1
198,PI3K-Akt signaling pathway WP4172,0.5691150444743437,1.0175493971340193,0.5735647938502413,"['CSF3R', 'MAPK1', 'FGF1']",0.620852775790193,0,0,3
199,DNA Repair Pathways Full Network WP4946,0.5795586710723866,1.169026169026169,0.6376901876433148,['TDG'],0.6290687082996759,0,0,1
200,Senescence and Autophagy in Cancer WP615,0.5852289799293602,1.1506545608108107,0.6164655854219069,['MAPK1'],0.632047298323709,0,0,1
201,Pancreatic adenocarcinoma pathway WP4263,0.5908233218520866,1.1328482328482328,0.5961480761765402,['MAPK1'],0.6349146145276154,0,0,1
202,Apoptosis Modulation and Signaling WP1772,0.5963427078161432,1.1155814905814905,0.5766884325299473,['TNFRSF11B'],0.637673390536074,0,0,1
203,Fragile X Syndrome  WP4549,0.6124610403049321,1.0667841754798277,0.5230122203746863,['MAPK1'],0.6516826832801248,0,0,1
204,DNA damage response (only ATM dependent) WP710,0.6379163672252386,0.9942476260043828,0.4469621213405297,['MAPK1'],0.6754408594149585,0,0,1
205,Gastrin signaling pathway WP4659,0.6428044949565744,0.9809009009009009,0.4334744806280766,['MAPK1'],0.6772964434664395,0,0,1
206,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.6662791299903799,0.9191722972972973,0.3732267697207262,['MAPK1'],0.6986227770772915,0,0,1
207,TGF-beta Signaling Pathway WP366,0.6839501570581016,0.8750804375804376,0.33241701042870253,['MAPK1'],0.7102559323295671,0,0,1
208,Hippo-Merlin Signaling Dysregulation WP4541,0.6839501570581016,0.8750804375804376,0.33241701042870253,['ITGB2'],0.7102559323295671,0,0,1
209,Ectoderm Differentiation WP2858,0.704737211957672,0.8255390221682356,0.28888111327591515,['TNFRSF11B'],0.7283408506356802,0,0,1
210,Integrated breast cancer pathway WP1984,0.7087286786575245,0.8162912912912913,0.2810348125472604,['MAPK1'],0.7289780694763108,0,0,1
211,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7278961541212714,0.772972972972973,0.24549380948609364,['MAPK1'],0.7451448781525811,0,0,1
212,Hepatitis B infection WP4666,0.7315765515195856,0.7648507882882883,0.23905672503148398,['MAPK1'],0.7453798826803325,0,0,1
213,Insulin Signaling WP481,0.7492498472696171,0.7266523949692266,0.20977203102436698,['MAPK1'],0.7598026620198933,0,0,1
214,Calcium Regulation in the Cardiac Cell WP536,0.7559910672542834,0.7124114405667804,0.1992798022038541,['CHRM5'],0.7630564043314262,0,0,1
215,Ras signaling WP4223,0.7983971029726602,0.6263571263571264,0.14102379497285264,['MAPK1'],0.8021105778702076,0,0,1
216,Circadian rhythm related genes WP3594,0.8091074416245796,0.6054277417913781,0.12824386128448384,['DRD1'],0.8091074416245796,0,0,1
